Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
15th United European Gastroenterology Week (UEGW)
Treatment Goals in IBD Evolve with Increasing Evidence that Mucosal Healing Is Critical to Favourable Long-term Outcome
Paris, France / October 27-31, 2007
Paris - The improvement in outcome associated with biologic therapies over other treatment options in inflammatory bowel disease (IBD) is being increasingly attributed to the greater likelihood of mucosal healing. In Crohn’s disease and...
15th United European Gastroenterology Week (UEGW)
Ulcerative Colitis: Promising New Findings for Rapid Symptom Relief
Paris, France / October 27-31, 2007
Paris - The lack of compliance to maintenance therapies in ulcerative colitis, particularly once symptoms have been controlled, has long been regarded as a major cause of relapses and complications. The recent introduction of a q.d....
15th United European Gastroenterology Week
Maintaining Remission Without Increasing Treatment Burden: Expanding Therapeutic Options
Paris, France / October 27-31, 2007
Editorial Overview: Brian G. Feagan, MD, FRCPC Once reserved for inflammatory bowel disease (IBD) refractory to other options, tumour necrosis factor alpha (TNF-a) inhibitors are being considered earlier in the treatment of...
72nd Annual Scientific Meeting of the American College of Gastroenterology
Ulcerative Colitis: Strategies to Keep Patients on Maintenance Therapies to Reduce Risk of Colectomy
Philadelphia, Pennsylvania / October 14-17, 2007
Philadelphia - Even though the vast majority of ulcerative colitis patients have only mild-to-moderate disease at presentation, the lifetime risk of colectomy is nearly one in three. Progression in many cases is thought to be due to the...
Digestive Disease Week 2007
Prolonging Control over Ulcerative Colitis
Washington, DC / May 20-23, 2007
Washington, DC - New data generated from extension trials in ulcerative colitis (UC) have demonstrated long-term control with newer therapies. While one study tested a biologic agent reserved for use in patients with refractory disease,...
45th Annual Meeting of the Canadian Association of Gastroenterology Canadian Digestive Diseases Week 2007
The Importance of Mucosal Healing in Ulcerative Colitis Patients
Banff, Alberta / February 16-20, 2007
Banff - Ulcerative colitis (UC) is a chronic inflammatory disorder of the colon of unknown etiology. It is characterized by mucosal ulceration, rectal bleeding, diarrhea and abdominal pain. Disease management of acute UC typically consists...
14th United European Gastroenterology Week
New Insights on Prevention of Colorectal Cancer in Patients with Inflammatory Bowel Disease
Berlin, Germany / October 21-25, 2006
Berlin - There is mounting evidence that 5-aminosalicylic acid (5-ASA) can lower the risk of developing colorectal cancer (CRC) in both Crohn’s disease and ulcerative colitis among patients with inflammatory bowel disease (IBD), yet the...
14th United European Gastroenterology Week
The Role of Biologics for Early and Sustained Control of Inflammatory Bowel Disease
Berlin, Germany / October 21-25, 2006
Berlin - New data are increasing the support for a “top-down” strategy in the treatment of moderate to severe inflammatory bowel disease (IBD), particularly Crohn’s disease. In IBD, this strategy refers to the practice of employing a...
71st Annual Scientific Meeting of the American College of Gastroenterology
Therapeutic Options for Patients with Ulcerative Colitis
Las Vegas, Nevada / October 21-25, 2006
Las Vegas -The availability of improved conventional and biologic therapies offers physicians greater choice to enhance the care of patients with ulcerative colitis (UC). Oral 5-aminosalicylic acid (5-ASA) is generally regarded as the...